| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |